Metis Global Partners LLC Raises Position in National Health Investors, Inc. $NHI

Metis Global Partners LLC lifted its stake in National Health Investors, Inc. (NYSE:NHI) by 34.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,719 shares of the real estate investment trust’s stock after purchasing an additional 1,964 shares during the period. Metis Global Partners LLC’s holdings in National Health Investors were worth $541,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Bank of New York Mellon Corp increased its holdings in National Health Investors by 3.2% in the second quarter. Bank of New York Mellon Corp now owns 607,913 shares of the real estate investment trust’s stock valued at $42,627,000 after buying an additional 19,042 shares during the last quarter. Aviance Capital Partners LLC grew its stake in National Health Investors by 3.8% during the 2nd quarter. Aviance Capital Partners LLC now owns 5,225 shares of the real estate investment trust’s stock worth $366,000 after buying an additional 189 shares during the last quarter. Strs Ohio raised its stake in National Health Investors by 424.7% during the 2nd quarter. Strs Ohio now owns 42,500 shares of the real estate investment trust’s stock valued at $2,980,000 after acquiring an additional 34,400 shares during the last quarter. Assetmark Inc. lifted its position in National Health Investors by 19.0% in the second quarter. Assetmark Inc. now owns 925 shares of the real estate investment trust’s stock valued at $65,000 after purchasing an additional 148 shares during the period. Finally, Teacher Retirement System of Texas boosted its position in shares of National Health Investors by 47.8% during the 2nd quarter. Teacher Retirement System of Texas now owns 9,865 shares of the real estate investment trust’s stock worth $692,000 after purchasing an additional 3,192 shares in the last quarter. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Trading Down 0.7%

NYSE:NHI opened at $76.21 on Thursday. The company has a market cap of $3.63 billion, a PE ratio of 24.35, a P/E/G ratio of 3.31 and a beta of 0.74. The business’s 50 day moving average is $76.71 and its two-hundred day moving average is $74.39. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75. National Health Investors, Inc. has a 52 week low of $65.13 and a 52 week high of $81.00.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.08. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The business had revenue of $83.36 million during the quarter, compared to the consensus estimate of $85.66 million. During the same period in the previous year, the business earned $1.03 EPS. The business’s quarterly revenue was down 1.8% on a year-over-year basis. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. On average, analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be issued a dividend of $0.92 per share. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $3.68 annualized dividend and a dividend yield of 4.8%. National Health Investors’s dividend payout ratio is 116.09%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on NHI shares. Wells Fargo & Company upped their price target on shares of National Health Investors from $76.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Wednesday, August 27th. Truist Financial boosted their price target on National Health Investors from $77.00 to $81.00 and gave the stock a “buy” rating in a report on Friday, August 15th. National Bankshares set a $90.00 price objective on shares of National Health Investors in a research note on Wednesday, October 1st. Weiss Ratings reissued a “buy (b-)” rating on shares of National Health Investors in a research note on Wednesday, October 8th. Finally, Cantor Fitzgerald assumed coverage on shares of National Health Investors in a report on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $84.83.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.